REPORT FROM THE 63rd ANNUAL MEETING OF THE AMERICAN ACADEMY OF NEUROLOGY (AAN), HONOLULU, HAWAII, APRIL 9-16, 2011 – A retrospective study of 491 MS patients reports that the serum lipid profile may adversely affect disease progression in MS patients (Weinstock-Guttman et al. AAN 2011; abstract P04.235). The chart review compared the results of lipid profile testing, MRI findings and EDSS scores at baseline and after >6 months’ follow-up.